- Home
- CDIO vs NITO Comparison
CDIO vs NITO Comparison
Compare CDIO & NITO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- NITO
- Stock Information
- Founded
- CDIO 2017
- NITO 2009
- Country
- CDIO United States
- NITO Israel
- Employees
- CDIO N/A
- NITO N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- NITO
- Sector
- CDIO Health Care
- NITO
- Exchange
- CDIO Nasdaq
- NITO NYSE
- Market Cap
- CDIO 7.9M
- NITO 7.8M
- IPO Year
- CDIO N/A
- NITO N/A
- Fundamental
- Price
- CDIO $3.44
- NITO $0.24
- Analyst Decision
- CDIO Buy
- NITO
- Analyst Count
- CDIO 1
- NITO 0
- Target Price
- CDIO $60.00
- NITO N/A
- AVG Volume (30 Days)
- CDIO 57.8K
- NITO 1.2M
- Earning Date
- CDIO 08-11-2025
- NITO 08-13-2025
- Dividend Yield
- CDIO N/A
- NITO N/A
- EPS Growth
- CDIO N/A
- NITO N/A
- EPS
- CDIO N/A
- NITO N/A
- Revenue
- CDIO $19,902.00
- NITO $232,000.00
- Revenue This Year
- CDIO $1,434.82
- NITO N/A
- Revenue Next Year
- CDIO $4,661.91
- NITO N/A
- P/E Ratio
- CDIO N/A
- NITO N/A
- Revenue Growth
- CDIO N/A
- NITO 24.74
- 52 Week Low
- CDIO $3.22
- NITO $0.16
- 52 Week High
- CDIO $53.10
- NITO $3.49
- Technical
- Relative Strength Index (RSI)
- CDIO 32.36
- NITO 42.39
- Support Level
- CDIO $3.65
- NITO $0.23
- Resistance Level
- CDIO $4.18
- NITO $0.26
- Average True Range (ATR)
- CDIO 0.31
- NITO 0.02
- MACD
- CDIO 0.12
- NITO -0.00
- Stochastic Oscillator
- CDIO 4.49
- NITO 14.95
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About NITO N2OFF INC
N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork. The Company has two reportable segments: Pathogen prevention and prolong shelf life, and the N2O emissions Global warming solutions.